Ticino Artificial InTelligence integrAtioN for Occlusion Myocardial Infarction

NANot yet recruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

September 30, 2027

Conditions
Myocardial Infarction (MI)Acute Coronary Syndrome (ACS)
Interventions
DIAGNOSTIC_TEST

AI-assisted ECG interpretation (PMcardio)

Participants in the experimental arm will undergo 12-lead ECG interpretation supported by a CE-marked artificial intelligence (AI) tool (PMcardio, Powerful Medical, Slovakia). The AI algorithm analyzes ECG data in real time to detect patterns suggestive of occlusion myocardial infarction (OMI), including cases not meeting traditional ST-elevation myocardial infarction (STEMI) criteria. In the experimental arm, the AI output is provided immediately to the treating clinician and used as an adjunct to standard ECG interpretation to support timely diagnosis and management decisions.

Trial Locations (1)

6900

Cardiocentro Ticino Institute, Lugano

All Listed Sponsors
lead

Cardiocentro Ticino

OTHER

NCT07077057 - Ticino Artificial InTelligence integrAtioN for Occlusion Myocardial Infarction | Biotech Hunter | Biotech Hunter